Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors.
Xin LiHan QiGou QingZe SongLin XieFei CaoXiaoming ChenWei-Jun FanPublished in: Thoracic cancer (2018)
The longer disease control observed in our patients suggests that continuation of EGFR-TKI beyond focal progression associated to microwave ablation is an efficacious therapeutic strategy.